Equillium Stock Fundamentals
EQ Stock | USD 0.72 0.02 2.86% |
Equillium fundamentals help investors to digest information that contributes to Equillium's financial success or failures. It also enables traders to predict the movement of Equillium Stock. The fundamental analysis module provides a way to measure Equillium's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Equillium stock.
At this time, Equillium's Interest Income is relatively stable compared to the past year. As of 11/22/2024, Interest Expense is likely to grow to about 748.9 K, while Net Loss is likely to drop (8.6 M). Equillium | Select Account or Indicator |
Equillium Company Operating Margin Analysis
Equillium's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Equillium Operating Margin | (0.01) % |
Most of Equillium's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Equillium is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, Equillium has an Operating Margin of -0.0072%. This is 99.98% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The operating margin for all United States stocks is 99.87% lower than that of the firm.
Equillium Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Equillium's current stock value. Our valuation model uses many indicators to compare Equillium value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Equillium competition to find correlations between indicators driving Equillium's intrinsic value. More Info.Equillium is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . At this time, Equillium's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Equillium by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Equillium Current Valuation Drivers
We derive many important indicators used in calculating different scores of Equillium from analyzing Equillium's financial statements. These drivers represent accounts that assess Equillium's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Equillium's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 58.7M | 108.9M | 108.6M | 35.8M | 25.1M | 23.9M | |
Enterprise Value | 55.2M | 93.2M | 68.2M | (13.2M) | 2.7M | 2.6M |
Equillium Fundamentals
Return On Equity | -0.34 | ||||
Return On Asset | -0.12 | ||||
Profit Margin | (0.20) % | ||||
Operating Margin | (0.01) % | ||||
Current Valuation | 62.83 K | ||||
Shares Outstanding | 35.43 M | ||||
Shares Owned By Insiders | 36.20 % | ||||
Shares Owned By Institutions | 20.03 % | ||||
Number Of Shares Shorted | 117.56 K | ||||
Price To Earning | (6.70) X | ||||
Price To Book | 1.10 X | ||||
Price To Sales | 0.60 X | ||||
Revenue | 36.08 M | ||||
Gross Profit | 15.76 M | ||||
EBITDA | (12.14 M) | ||||
Net Income | (13.34 M) | ||||
Cash And Equivalents | 57.56 M | ||||
Cash Per Share | 1.68 X | ||||
Total Debt | 824 K | ||||
Debt To Equity | 0.29 % | ||||
Current Ratio | 3.98 X | ||||
Book Value Per Share | 0.64 X | ||||
Cash Flow From Operations | (21.78 M) | ||||
Short Ratio | 0.53 X | ||||
Earnings Per Share | (0.12) X | ||||
Target Price | 3.33 | ||||
Number Of Employees | 45 | ||||
Beta | 1.83 | ||||
Market Capitalization | 25.44 M | ||||
Total Asset | 50.53 M | ||||
Retained Earnings | (185.74 M) | ||||
Working Capital | 21.78 M | ||||
Current Asset | 60.04 M | ||||
Current Liabilities | 1.81 M | ||||
Net Asset | 50.53 M |
About Equillium Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Equillium's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Equillium using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Equillium based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for Next Year | ||
Current Deferred Revenue | 15.7 M | 16.7 M | |
Total Revenue | 36.1 M | 37.9 M | |
Cost Of Revenue | 126 K | 132.3 K | |
Stock Based Compensation To Revenue | 0.11 | 0.11 | |
Sales General And Administrative To Revenue | 0.38 | 0.36 | |
Research And Ddevelopement To Revenue | 1.03 | 1.87 | |
Revenue Per Share | 1.04 | 0.60 | |
Ebit Per Revenue | (0.40) | (0.42) |
Pair Trading with Equillium
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Equillium position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will appreciate offsetting losses from the drop in the long position's value.Moving against Equillium Stock
The ability to find closely correlated positions to Equillium could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equillium when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equillium - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equillium to buy it.
The correlation of Equillium is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equillium moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equillium moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equillium can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Equillium Stock Analysis
When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.